Accelerated growth of skin carcinoma following fludarabine therapy for chronic lymphocytic leukemia

References

• Huang P, Chubb S, Plunkett W. Termination of DYN synthesis by 9-B-D-arabinofuranosy1-2-fluroadenine. J Biol Chem 1990;265: 16–17.
   Google Scholar
• Yang S-W, Huang P, Plunkett W, Becker FF, Chan YH. Dual mode of inhibition of purified DNA ligase I from human cells by 9-B-D-arabinofuranosy1-2-fluroadenine troposphere.J Biol Chem 1992;267: 23–45.
   Google Scholar
• Puccio CA, Mittelman A, Lichtman SM, Sliver RT, Budman DR, Ahmed T, Feldman EJ, Coleman M, Arnold PM, Arlin ZA, Chun HG. A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia. J Chin Oncology 1991;9:1562–1569.
   Google Scholar
• Carson DA, Carrera CJ, Wasson DB, Yamanaka H. Pro-grammed cell death and adenine nucleotide metabolism in human lymphocytes. Adv Enzyme Regul 1987;27:395–404.
   Google Scholar
• Carson DA, Seto S, Wasson DB, Carrera CJ. DNA strand breaks, NAD metabolism and programmed cell death. Exp Cell Res 1986;164:273–281.
   PubMed Web of Science ®Google Scholar
• Carson DA, Wasson DB, Beutler E. Antileukemic immuno-suppressive activity of 2-chloro-2'-deoxyadenosine. Proc Natl Sci USA 1984;81: 2232–2236.
   Google Scholar
• Mengubas K, Riordan FA, Bravery CA, Lewis J, Owens DL, Mehta AB, Hoffbrand AV, Wickremasinghe RG. Ceramide induced killing of normal and malignant human lymphocytes is by a non-apoptotic mechanism. Oncogene 1999;18: 2499–2506.
   PubMed Web of Science ®Google Scholar
• Dighiero G. Adverse and beneficial immunological effects of purine nucleoside analogues. Hematology Cell Ther 1996;38:S75–S81.
   PubMedGoogle Scholar
• Donofrio J, Coleman MS, Hutton JJ, et al. Overproduction of adenosine deoxynucleosides and deoxynucleotides in adenosine deaminase deficiency with severe combined immunodeficiency disease. J Chin Invest 1978;62:884–887.
   PubMed Web of Science ®Google Scholar
• Wilson PK, Szabados E, Muigan SP, Christopherson RI. Comparative effects of cladribine, fludarabine and pentostatin on nucleotide metabolism in T and B cell lines. Int Biochem Cell Biol 1998;30:833–842.
   PubMed Web of Science ®Google Scholar
• Frank DA, Mahajan S & Ritz J. Fludarabine induced immunosuppression is associated with inhibition of STAT 1 signaling. Nature Med 1997;5: 444–447.
   Google Scholar
• Keating MJ, O'Brien S, Lerner S, Koller C, Beran M, Robertson LE, Freireich EJ, Estey E. Long-term follow up of patients with CLL receiving fludarabine regimes as initial therapy. Blood 1998;92:1165–1171.
   PubMed Web of Science ®Google Scholar
• Kolb HJ, Socie G, Duell Th, Van Lint MT, Tichelli A, Apperley JF, Nekolla E, Ljungman, P, Jacobsen PN, van Weel M, Weiss M, Prentice HG. Malignant neoplasm in long term survivors of bone marrow transplantation. Ann Int Med 1999;131:738–744.
   Google Scholar
• Davidovitz Y, Bailin A, Meytes D. Squamous cell carcinoma of the skin acceleration of development and growth complicat-ing chronic lymphocytic leukemia. Acta Haemtol 1997;98:4446.
   Google Scholar
• Sager D, Fulman M, Prasd C, Rivera Y, Hirschman R. Squamous cell carcinoma of the skin: Acceleration of development and growth complicating chronic lymhpocy-tic leukemia treatment with fludarabine (abstract). Proceedings of ASCO vol. 1997:37a.
   Google Scholar
• Deng JS, Brod BA, Saito R, Tharp MD Immune associated cells in basal cell carcinomas of skin. J Cutaneous Pathol 1996;23:140–146.
   PubMed Web of Science ®Google Scholar
• Deng JS, Falo LD Jr., Kim B, Abell E. Cytotoxic T cells in basal cell carcinoma of skin. Am J Dermatopathol 1998;20:143–146.
   Google Scholar
• Czarnecki D, Mar A, Kulinskaya E. Cell mediated immunity of patients who have had basal cell carcinomas. Acto Dermato-Venerolog 1996;76:28–30.
   Google Scholar
• Anaissie EJ, Kontoyiannis DP, O'Brien S, Kantarjian H, Robertson L, Lerner S, Keating MJ. Infections in patients with chronic lymphocytic leukemia treated with fludarabine. Ann Int Med 1998;129:559–566.
   Google Scholar
• Mihalov ML, Gattuso P, Abraham K, Holmes EW, Reddy V. Incidence of post transplant malignancy among 674 solid-organ transplant recipients at a single center. Chin Transplan-tation 1996;10: 248–255.
   Google Scholar
• Coso D, Costello R, Cohen-Valensi R, Nezri M, Gastaut JA & Bouaddullah R. Acute myeloid leukemia and myelodysplasia in patients with chronic lymphocytic leukemia receiving fludarabine as initial therapy. Ann Oncol 1999;10:362–363.
   Google Scholar
• Frewin RJ, Provan D, Smith AG. Myelodysplasia occurring after fludarabine treatment for chronic lymphocytic leukemia. Chin Lab Ham 1997;19:151–152.
   Google Scholar
• Robertson LE, Estey E, Kantarjian H, Koller C, O'Brien S, Brown B, Keating MJ. Therapy related leukemia and myelodysplastic syndrome in chronic lymphocytic leukemia. Leukemia 1994;8:2047–2051.
   PubMed Web of Science ®Google Scholar
• Sheilds DJ, Byrd JC, Abbondanzo SL, et al. Detection of EBV in transformation of low grade B cell lymphomas treatment. Md Pathol 1997;10:1551–1559.
   Google Scholar
• Palmera L, Azaceta G, Varo MJ, Soria J, Gutierrez M. Fatal myelofibrosis following fludarabine administration in a patient with indolent lymphoma (letter). Hematologica 1998;83: 10045–10046.
   Google Scholar
• Larsen CR, Hansen PB, Clausen NT. Aggressive growth of epithelial carcinomas following treatment with nucleoside analogues. Am J Hematol 2002;70:48–50.
   Google Scholar